Cancer starts when some of a person’s cells become cancerous. New drug therapies re-program a patient’s own cells so they will become tumor-specific cells that destroy the cancerous cells. ImmunoDigest.com, a new database, will include hundreds of success stories where patients have had treatments and are alive despite a terminal diagnosis. Names of doctors, hospitals, and immunologic therapies will be included.

Carlsbad, CA, May 12, 2017 /PressReleasePing/ – ImmunoDigest.com is pleased to announce the development of a free, comprehensive, online searchable database of immunological therapies. Immunological therapies are being used in major hospitals worldwide, some of which include America’s Memorial Sloan Kettering Cancer Center, Stanford University, University of Pennsylvania, and the Texas MD Anderson Cancer Center.

ImmunoDigest.com is a database of patient success stories that is searchable by:

cancer type
cancer location (breast, spleen, lungs, stomach, etc.)
immunologic therapies used
hospital or research facility
doctor
country of treatment
sources of information (with an active link to the survivor’s success story)

Patients, families and even doctors will be able to search for possible cures to their particular cancer.

Understanding immunologic therapies simplified: Cancer starts when some of a person’s cells become cancerous. These cancer cells can become a blood, bone, lung or another type of cancer, which may evolve to become tumors. For some cancers, new drug therapies use the patient’s own cells to re-program themselves into tumor-specific T-cells. These re-programmed cells become “weapons” that will destroy the cancerous cells – ideally forever! It is essentially a personalized medicine as everyone’s cancer is different.

Visit https://igg.me/at/ImmunoDigest to learn more about this incredible new database which tells the stories of lung cancer, lymphoma, brain cancer and other cancer survivors.

ImmunoDigest.com is based in San Diego County in the city of Carlsbad in the state of California, USA. John Livingstone, the founder, is passionate about spreading information to patients about possible cures through immunologic therapies. Cancer.gov estimates 39% of Americans will be diagnosed with cancer. This information is a valuable resource.

###

Press Contact:
John Livingstone
Founder / President
ImmunoDigest.com
7040 Avenida Encinas, Suite 10488 Carlsbad, CA 92011
http://immunodigest.com/